Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Sangamo Therapeutics, Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 182
- −14 vs. Q3 2022
- Shares held
- 104.0M
- +6.60M (+6.8%) vs. Q3 2022
- Total value
- $326.0M
- −$151.2M (−31.7%) vs. Q3 2022
- New holders
- 17
- 63 more added
- Sold out
- 31
- 59 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −11,956−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,671−100.0% | Sold out |
| Axiom Investment Management LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,800−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Hudock, Inc. | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |
| Investors Asset Management of Georgia Inc | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Westside Investment Management, Inc. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Castle Wealth Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| HHM Wealth Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |